Clinical trial
Treatment of Nonalcoholic Steatohepatitis With Pioglitazone
NCT00013598 · National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), NIH · Completed
Key facts
| NCT number | NCT00013598 |
|---|---|
| Title | Treatment of Nonalcoholic Steatohepatitis With Pioglitazone |
| Official title | Treatment of Nonalcoholic Steatohepatitis With Pioglitazone |
| Lead sponsor | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Fatty Liver, Nonalcoholic Steatohepatitis |
| Intervention type | Drug |
| Interventions | Pioglitazone |
| Enrollment | 30 |
| Start date | Mar 1, 2001 |
| Completion | Mar 1, 2004 |
| First posted | Mar 26, 2001 |
| Last update posted | Mar 4, 2008 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: